Aileen E Allsop

494 total citations
9 papers, 378 citations indexed

About

Aileen E Allsop is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Aileen E Allsop has authored 9 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Pharmacology and 2 papers in Genetics. Recurrent topics in Aileen E Allsop's work include Microbial Natural Products and Biosynthesis (3 papers), Genomics and Phylogenetic Studies (3 papers) and Biochemical and Structural Characterization (2 papers). Aileen E Allsop is often cited by papers focused on Microbial Natural Products and Biosynthesis (3 papers), Genomics and Phylogenetic Studies (3 papers) and Biochemical and Structural Characterization (2 papers). Aileen E Allsop collaborates with scholars based in United Kingdom, United States and Costa Rica. Aileen E Allsop's co-authors include John Rosamond, M. BLACK, Robert Southgate, Arun C. Kaura, Gerald Brooks, Peter Edwards, Robert S. Illingworth, G. Holt, Steven Coulton and Gordon Bruton and has published in prestigious journals such as Science, Biochemical Journal and Current Opinion in Biotechnology.

In The Last Decade

Aileen E Allsop

9 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aileen E Allsop United Kingdom 9 268 95 75 57 51 9 378
Ahmed El Zoeiby Canada 7 322 1.2× 177 1.9× 69 0.9× 52 0.9× 65 1.3× 9 520
Klaus‐Peter Koller Germany 9 303 1.1× 50 0.5× 37 0.5× 50 0.9× 113 2.2× 12 447
Lefa Alksne United States 13 640 2.4× 101 1.1× 46 0.6× 70 1.2× 106 2.1× 15 781
Paul Balbo United States 9 278 1.0× 107 1.1× 77 1.0× 28 0.5× 110 2.2× 11 549
Vladimir Vimberg Czechia 12 313 1.2× 102 1.1× 47 0.6× 40 0.7× 64 1.3× 21 473
Akihiro Doi Japan 8 273 1.0× 148 1.6× 77 1.0× 30 0.5× 99 1.9× 14 447
Jitender Mehla United States 13 241 0.9× 60 0.6× 63 0.8× 27 0.5× 49 1.0× 21 426
Ingrid Kleber Germany 11 195 0.7× 67 0.7× 78 1.0× 33 0.6× 70 1.4× 26 387
J. Janeček Czechia 11 312 1.2× 88 0.9× 36 0.5× 69 1.2× 60 1.2× 43 473
Jos A. M. van de Klundert Netherlands 10 155 0.6× 81 0.9× 43 0.6× 40 0.7× 58 1.1× 21 378

Countries citing papers authored by Aileen E Allsop

Since Specialization
Citations

This map shows the geographic impact of Aileen E Allsop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen E Allsop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen E Allsop more than expected).

Fields of papers citing papers by Aileen E Allsop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aileen E Allsop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen E Allsop. The network helps show where Aileen E Allsop may publish in the future.

Co-authorship network of co-authors of Aileen E Allsop

This figure shows the co-authorship network connecting the top 25 collaborators of Aileen E Allsop. A scholar is included among the top collaborators of Aileen E Allsop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen E Allsop. Aileen E Allsop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Allsop, Aileen E & Robert S. Illingworth. (2002). The impact of genomics and related technologies on the search for new antibiotics. Journal of Applied Microbiology. 92(1). 7–12. 12 indexed citations
2.
Rosamond, John & Aileen E Allsop. (2000). Harnessing the Power of the Genome in the Search for New Antibiotics. Science. 287(5460). 1973–1976. 135 indexed citations
3.
Allsop, Aileen E. (1998). New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. Current Opinion in Microbiology. 1(5). 530–534. 50 indexed citations
4.
Allsop, Aileen E. (1998). Bacterial genome sequencing and drug discovery. Current Opinion in Biotechnology. 9(6). 637–642. 19 indexed citations
5.
Allsop, Aileen E, Gerald Brooks, Peter Edwards, Arun C. Kaura, & Robert Southgate. (1996). Inhibitors of Bacterial Signal Peptidase: A Series of 6-(Substituted oxyethyl)penems.. The Journal of Antibiotics. 49(9). 921–928. 35 indexed citations
6.
Allsop, Aileen E, Gerald Brooks, Gordon Bruton, et al.. (1995). Penem inhibitors of bacterial signal peptidase. Bioorganic & Medicinal Chemistry Letters. 5(5). 443–448. 43 indexed citations
7.
BLACK, M., et al.. (1992). On the catalytic mechanism of prokaryotic leader peptidase 1. Biochemical Journal. 282(2). 539–543. 61 indexed citations
8.
Saunders, Gunter, et al.. (1982). Modern developments in mutagenesis. Journal of Chemical Technology and Biotechnology. 32(1). 354–364. 9 indexed citations
9.
Allsop, Aileen E, et al.. (1981). Intergeneric Cosynthesis of Penicillin by Strains of Penicillium chrysogenum, P. chrysogenum/notatum and Aspergillus nidulans. Microbiology. 122(2). 339–343. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026